PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data methods and opinion in the emerging discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research invited reviews and a variety of guest editorials and commentaries embracing scientific medical statistical and legal aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Communication. Particular areas of interest include: design results analysis and interpretation of post-marketing surveillance and other studies looking at specific drugs populations and outcomes methods for detection and evaluation of drug-associated adverse events assessments of risk versus benefit ratios in drug therapy patterns of drug utilization relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines The Publishers recognize the need of journal users to access articles through a variety of channels and are committed to providing a wide range of options in the future. The Publishers are also aware that new communication media increase the threat to authors' own rights through unauthorized distribution alteration or attribution. To enable the Publishers to make the published version of articles available as widely as possible while protecting authors' rights to be associated with their work it is essential that a Copyright Transfer Agreement form is signed for every article which is to be considered for publication in the journal. The form can be photocopied from the journal or copies can be obtained on request from the Publisher or printed from this Web site. Inclusion of a signed form with the manuscript at the original submission stage will speed up processing and eventual publication of the article.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY期刊中文简介

药物流行病学和药物安全的目的是为药物流行病学新兴学科中数据方法和意见的交流和评价提供一个国际论坛。该杂志出版了原创研究的同行评审报告，邀请评审和各种客座社论和评论，包括药物流行病学的科学医学统计和法律方面以及上市后药品安全监测。这些类别的适当材料也可考虑作为简短的通讯材料出版。特别感兴趣的领域包括:设计结果分析和解释在特定药物的上市后监测和其他研究人口和结果的方法检测和评估药物相关不良事件的评估风险和收益比率在药物治疗的药物利用药物之间的关系模式的制定和解释监管指南杂志的出版商认识到需要通过各种各样的用户访问的文章并致力于在未来提供广泛的选择。出版商也意识到，新的传播媒体通过未经授权的发行变更或署名，增加了对作者自身权利的威胁。为了使出版商能够在保护作者与其作品关联的权利的同时尽可能广泛地提供已出版的文章版本，有必要为每一篇考虑在期刊上发表的文章签署一份版权转让协议表格。本表格可由刊物影印，亦可按出版商要求索取或从本网站列印。在原始提交阶段，连同稿件一起附上已签署的表格，将加快文章的处理和最终出版速度。